Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BeAT1D: Benign Autoimmunity and Type 1 Diabetes

NCT05139784 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT05139784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BeAT1D: Benign Autoimmunity and Type 1 Diabetes
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Observational
Overall status
Recruiting
Start date
October 24, 2022
Completion date
April 30, 2030
Enrollment
1,160 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes